Media

All media queries to be directed to Lucy Jones via mobile: 0406 991606 or email: [email protected]

Latest news

Visit our news area or our social media pages for more news and information regarding Neuroblastoma Australia.

Media releases

2 February 2020 - CHILDREN’S CANCER CHARITY FUNDS RESEARCH AS #2LITTLE IS BEING DONE FOR NEUROBLASTOMA BABIES
12 December 2019 - FUNDING FOR EXCITING NEW GROUNDBREAKING RESEARCH PROJECTS
5 September 2019 - ITS CHILDREN’S CANCER AWARENESS MONTH – GIVE A GIFT OF HOPE
28 August 2019 - WORLD EXPERTS JOIN AUSTRALIAN CHILDREN’S CANCER BOARD
19 August 2019 - HOPE2CURE - Give a gift of Hope for Children’s Cancer Awareness Month

Media coverage

March 2022 - The Project : Grieving Parents Turn Loss Into Hope For Cure For Neuroblastoma
Jun 2021 - The Daily Telegraph: Run2Cure: Wesley Wadds inspires others to fight neuroblastoma
May 2021 - ABC News: Ground-breaking research for neuroblastoma feat. Lucy Jones
April 2020 - North Shore Mums: Why we need to Run2Cure for kids like Benji
March 2020 - The Daily Telegraph: The road to recovery neuroblastoma
March 2020 - The Adelaide Advertiser: 44KM for 44 childhood cancer sufferers
March 2020 - The Daily Telegraph: Neuroblastoma Australia's 2020 Run2Cure to fund vital research
February 2020 - The Daily Telegraph (body+soul): My charity keeps me connected to my girl

Lucy Jones in the newspaper

Give a gift to a child with cancer

Brighten a child's day - for as little as $59, you can gift a child with neuroblastoma a fun Activity Pack to keep them entertained and engaged whilst isolated indoors at home or in hospital.

Latest

Golf2Cure 2024

Golf2Cure 2024 will take place on Friday, September 6. We're returning to the hugely popular St Michael’s Golf Club, Little Bay to raise vital funds for research into neuroblastoma childhood cancer. Book your spot today!
Eli's Pit Crew

Our son Eli was diagnosed with stage four neuroblastoma in July 2023, at the young age of nine months.After a traumatic start to his diagnosis which placed him in life threatening condition, Eli survived four courses of chemotherapy and numerous health complications.
Call to Federal Government for equitable access to DFMO

DFMO (eflornithine) was approved in December 2023 by FDA for treatment of high-risk neuroblastoma as a maintenance therapy to reduce the risk of relapse
Jackson's Story

Shortly before his first birthday, Jackon's family noticed he had developed a limp in his right leg. Further tests revealed Jackson had neuroblastoma. His dad, Andrew, shares their story.